Fig. 2: Cytogenetic analysis and risk stratification of CCUS and MDS patients.
From: Genomic landscape of CCUS compared to MDS and its implications on risk prediction
A Frequency of specific chromosomal abnormalities in CCUS and MDS patients (left panel) and distribution of the five IPSS-R cytogenetic risk groups within CCUS and MDS patients. Frequency of patients with Y-loss was adjusted for males only. Indep.: independent. B Distribution of the five IPSS-R risk categories within CCUS and MDS patients. C Distribution of the six IPSS-M risk categories within CCUS and MDS patients. ** p < 0.001; * p < 0.05; ns not significant.
